# Biotech Daily Digest — 2026-02-06

**30 items from 3 sources**

## Summary by Source

- Endpoints News: 8 items
- Fierce Biotech: 7 items
- arXiv q-bio: 15 items


## Endpoints News

- **[Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi](https://endpoints.news/geoff-mcdonoughs-big-plans-for-nodtheras-nlrp3-enhertu-leader-steps-down-at-daiichi/)**  
  _Fri, 06 Feb 2026 12:00:41 +0000_  
  Geoff McDonough is tipping his hat to one of the hottest targets in drug development right now.

 The former Generation Bio CEO has joined NodThera to get its NLRP3 program into Phase 3 next year ...

- **[Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis](https://endpoints.news/roivant-spinout-priovant-touts-phase-2-brepocitinib-data-in-cutaneous-sarcoidosis/)**  
  _Fri, 06 Feb 2026 12:00:30 +0000_  
  Priovant Therapeutics, a Roivant spinout, announced that an experimental immune drug it inherited from Pfizer succeeded in a Phase 2 trial for cutaneous sarcoidosis, a rare condition that causes small bumps or ...

- **[Illumina bets on healthcare after Trump administration's NIH funding disruptions](https://endpoints.news/illumina-bets-on-healthcare-after-trump-administrations-nih-funding-disruptions/)**  
  _Fri, 06 Feb 2026 09:19:24 +0000_  
  DNA sequencing company Illumina is leaning more into healthcare after its traditional research market was rattled by the Trump administration's disruptions to NIH funding.

 After a string of largely ...

- **[Veradermics CEO has a great hair day with 122% pop in IPO](https://endpoints.news/veradermics-ceo-has-a-great-hair-day-with-122-pop-in-ipo/)**  
  _Thu, 05 Feb 2026 18:34:42 +0000_  
  Investors are showing some love to the biotech testing an oral form of Rogaine, betting that people will want good hair too as the aesthetics market surges with direct-to-consumer GLP-1s.

 Veradermics' stock surged 122% in ...

- **[#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial](https://endpoints.news/isc26-bayers-asundexian-reduced-ischemic-strokes-by-26-in-phase-3-trial/)**  
  _Thu, 05 Feb 2026 17:15:12 +0000_  
  Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention.

 The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...

- **[Bristol Myers draws pipeline excitement as several data readouts near](https://endpoints.news/bristol-myers-draws-pipeline-excitement-as-several-data-readouts-near/)**  
  _Thu, 05 Feb 2026 15:50:01 +0000_  
  For the first time in a while, investors seem excited about Bristol Myers Squibb’s late-stage pipeline.

 Bristol Myers on Thursday flagged at least 10 potential data readouts coming this year that could lead to new ...

- **[GLP-1s and the Super Bowl](https://endpoints.news/glp-1s-and-the-super-bowl/)**  
  _Thu, 05 Feb 2026 15:41:48 +0000_  
  The Super Bowl is once again getting the GLP-1 ad treatment.

 Hims & Hers is back with another combative spot that calls out the disparities in healthcare experiences between the ...

- **[Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex](https://endpoints.news/thermo-fisher-charles-river-workforce-cuts-wuxi-signs-contract-with-vertex/)**  
  _Thu, 05 Feb 2026 15:22:33 +0000_  
  Thermo Fisher Scientific is closing its chemical analysis manufacturing site in Franklin, MA, due to “current customer demands,” a company spokesperson told Endpoints News. Operations there will be phased out by the end of the ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/chutes-ladders-moderna-cmo-steps-down-leadership-mix" hreflang="en">Chutes &amp; Ladders—Moderna CMO steps down in leadership mix-up</a>](https://www.fiercebiotech.com/biotech/chutes-ladders-moderna-cmo-steps-down-leadership-mix)**  
  _Feb 5, 2026 5:39pm_  
  Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. Miller held the role since November 2024 and will stay on as a consultant “to assist with the transition.”

- **[<a href="https://www.fiercebiotech.com/biotech/pfizer-backed-priovant-scores-again-fast-rising-brepocitinib-mid-stage-study" hreflang="en">Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study</a>](https://www.fiercebiotech.com/biotech/pfizer-backed-priovant-scores-again-fast-rising-brepocitinib-mid-stage-study)**  
  _Feb 5, 2026 3:39pm_  
  As Priovant works toward approval of potential blockbuster brepocitinib as a treatment for dermatomyositis, the North Carolina biotech has presented promising results for the TYK2/JAK1 inhibitor in another rare skin condition.

- **[<a href="https://www.fiercebiotech.com/medtech/nice-greenlights-abbotts-cardiac-sensor-implant-nhs" hreflang="en">NICE greenlights Abbott's cardiac sensor implant for NHS </a>](https://www.fiercebiotech.com/medtech/nice-greenlights-abbotts-cardiac-sensor-implant-nhs)**  
  _Feb 6, 2026 3:46am_  
  Abbott’s wireless, paperclip-sized cardiac sensor has received the blessing of the National Institute for Health and Care Excellence, paving the way for coverage of the device in England’s National Health Service.

- **[<a href="https://www.fiercebiotech.com/biotech/agomab-spyglass-head-nasdaq-ipos-totalling-350m" hreflang="en">Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M</a>](https://www.fiercebiotech.com/biotech/agomab-spyglass-head-nasdaq-ipos-totalling-350m)**  
  _Feb 6, 2026 4:05am_  
  Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this morning as momentum continues to build for biopharma IPOs.

- **[<a href="https://www.fiercebiotech.com/biotech/racing-bms-and-jj-bayer-links-asundexian-26-stroke-reduction-unblock-path-fda" hreflang="en">Racing BMS and J&amp;J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA</a>](https://www.fiercebiotech.com/biotech/racing-bms-and-jj-bayer-links-asundexian-26-stroke-reduction-unblock-path-fda)**  
  _Feb 5, 2026 4:54am_  
  Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and Johnson & Johnson’s rival factor XIa inhibitor in a blockbuster indication.

- **[<a href="https://www.fiercebiotech.com/biotech/angitia-raises-130m-challenge-amgen-bone-building-bispecifics" hreflang="en">Angitia raises $130M to challenge Amgen with bone-building bispecifics</a>](https://www.fiercebiotech.com/biotech/angitia-raises-130m-challenge-amgen-bone-building-bispecifics)**  
  _Feb 5, 2026 9:34am_  
  Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, revealing a $130 million series D financing that positions the biotech to take three bone disease prospects deeper into the clinic.

- **[<a href="https://www.fiercebiotech.com/pharma/cut-above-hair-regrowth-biotech-veradermics-locks-oversubscribed-256m-ipo" hreflang="en">A cut above: Veradermics locks in $256M IPO and shares spike</a>](https://www.fiercebiotech.com/pharma/cut-above-hair-regrowth-biotech-veradermics-locks-oversubscribed-256m-ipo)**  
  _Feb 5, 2026 9:43am_  
  In its initial public offering, Veradermics sold a little over 15 million shares of common stock at $17 apiece, raising a total of $256.3 million in its entry onto the New York Stock Exchange, according to a Securities and Exchange Commission filing. Veradermics is trading under the symbol "MANE."


## arXiv q-bio

- **[Beyond Independent Genes: Learning Module-Inductive Representations for Gene Perturbation Prediction](https://arxiv.org/abs/2602.04901)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04901v1 Announce Type: new 
Abstract: Predicting transcriptional responses to genetic perturbations is a central problem in functional genomics. In practice, perturbation responses are rarely gene-independent but instead manifest as coordinated, program-level transcriptional changes among functionally relat…

- **[AFD-INSTRUCTION: A Comprehensive Antibody Instruction Dataset with Functional Annotations for LLM-Based Understanding and Design](https://arxiv.org/abs/2602.04916)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.04916v1 Announce Type: new 
Abstract: Large language models (LLMs) have significantly advanced protein representation learning. However, their capacity to interpret and design antibodies through natural language remains limited. To address this challenge, we present AFD-Instruction, the first large-scale in…

- **[Combination therapy for colorectal cancer with anti-PD-L1 and cancer vaccine: A multiscale mathematical model of tumor-immune interactions](https://arxiv.org/abs/2602.05118)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05118v1 Announce Type: new 
Abstract: The tumor-immune system plays a critical role in colorectal cancer progression. Recent preclinical and clinical studies showed that combination therapy with anti-PD-L1 and cancer vaccines improved treatment response. In this study, we developed a multiscale mathematical…

- **[Learning virulence-transmission relationships using causal inference](https://arxiv.org/abs/2602.05196)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05196v1 Announce Type: new 
Abstract: The relationship between traits that influence pathogen virulence and transmission is part of the central canon of the evolution and ecology of infectious disease. However, identifying directional and mechanistic relationships among traits remains a key challenge in var…

- **[Specieslike clusters based on identical ancestor points](https://arxiv.org/abs/2602.05274)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05274v1 Announce Type: new 
Abstract: We introduce several axioms which may or may not hold for any given subgraph of the directed graph of all organisms (past, present and future) where edges represent biological parenthood, with the simplifying background assumption that life does not go extinct. We argue…

- **[Somatic Mechanotherapy Activates a Spatiotemporally Synchronized CPTC Wnt Axis for Gut Regeneration](https://arxiv.org/abs/2602.05451)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05451v1 Announce Type: new 
Abstract: Somatic mechanical stimulation (e.g., acupuncture) exerts systemic immunomodulatory effects, yet the cellular bridge translating peripheral physical force into visceral repair remains elusive. Here, employing a custom interpretable deep learning framework (CARSS) on sin…

- **[Intermittent precipitation and spatial Allee effects drive irregular vegetation patterns in semiarid ecosystems](https://arxiv.org/abs/2602.05583)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05583v1 Announce Type: new 
Abstract: Vegetation in semi-arid ecosystems frequently organizes into spatially heterogeneous mosaics that regulate ecosystem functioning, productivity, and resilience. These patterns arise from local biological interactions, including facilitation among neighboring plants and c…

- **[A novel scalable high performance diffusion solver for multiscale cell simulations](https://arxiv.org/abs/2602.05017)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05017v1 Announce Type: cross 
Abstract: Agent-based cellular models simulate tissue evolution by capturing the behavior of individual cells, their interactions with neighboring cells, and their responses to the surrounding microenvironment. An important challenge in the field is scaling cellular resolution…

- **[Characterizing Human Semantic Navigation in Concept Production as Trajectories in Embedding Space](https://arxiv.org/abs/2602.05971)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.05971v1 Announce Type: cross 
Abstract: Semantic representations can be framed as a structured, dynamic knowledge space through which humans navigate to retrieve and manipulate meaning. To investigate how humans traverse this geometry, we introduce a framework that represents concept production as navigatio…

- **[Mechanisms of AI Protein Folding in ESMFold](https://arxiv.org/abs/2602.06020)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2602.06020v1 Announce Type: cross 
Abstract: How do protein structure prediction models fold proteins? We investigate this question by tracing how ESMFold folds a beta hairpin, a prevalent structural motif. Through counterfactual interventions on model latents, we identify two computational stages in the folding…

- **[Transformer brain encoders explain human high-level visual responses](https://arxiv.org/abs/2505.17329)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2505.17329v3 Announce Type: replace 
Abstract: A major goal of neuroscience is to understand brain computations during visual processing in naturalistic settings. A dominant approach is to use image-computable deep neural networks trained with different task objectives as a basis for linear encoding models. Howe…

- **[Load Transfer along Continuous Collagen Fibers Reduces the Importance of Wall Thickness Variations](https://arxiv.org/abs/2509.25501)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2509.25501v2 Announce Type: replace 
Abstract: The mechanical response of biological soft tissues is influenced by wall heterogeneity, including spatial variations in wall thickness. Traditional models for homogeneous soft tissues under uniaxial loading predict higher stretch and stress in thinner regions. In fa…

- **[Controlling tissue size by active fracture](https://arxiv.org/abs/2503.03126)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2503.03126v3 Announce Type: replace-cross 
Abstract: Groups of cells, including clusters of cancerous cells, multicellular organisms, and developing organs, may both grow and break apart. What physical factors control these fractures? In these processes, what sets the eventual size of clusters? We first develop…

- **[Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinoma](https://arxiv.org/abs/2505.04672)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2505.04672v3 Announce Type: replace-cross 
Abstract: Recent advancements in digital pathology have enabled comprehensive analysis of Whole-Slide Images (WSI) from tissue samples, leveraging high-resolution microscopy and computational capabilities. Despite this progress, there is a lack of labeled datasets and o…

- **[CellForge: Agentic Design of Virtual Cell Models](https://arxiv.org/abs/2508.02276)**  
  _Fri, 06 Feb 2026 00:00:00 -0500_  
  arXiv:2508.02276v2 Announce Type: replace-cross 
Abstract: Virtual cell modeling aims to predict cellular responses to diverse perturbations but faces challenges from biological complexity, multimodal data heterogeneity, and the need for interdisciplinary expertise. We introduce CellForge, a multi-agent framework that…
